» Articles » PMID: 24146838

Defining Metabolically Healthy Obesity: Role of Dietary and Lifestyle Factors

Overview
Journal PLoS One
Date 2013 Oct 23
PMID 24146838
Citations 100
Authors
Affiliations
Soon will be listed here.
Abstract

Background: There is a current lack of consensus on defining metabolically healthy obesity (MHO). Limited data on dietary and lifestyle factors and MHO exist. The aim of this study is to compare the prevalence, dietary factors and lifestyle behaviours of metabolically healthy and unhealthy obese and non-obese subjects according to different metabolic health criteria.

Method: Cross-sectional sample of 1,008 men and 1,039 women aged 45-74 years participated in the study. Participants were classified as obese (BMI ≥ 30 kg/m(2)) and non-obese (BMI < 30 kg/m(2)). Metabolic health status was defined using five existing MH definitions based on a range of cardiometabolic abnormalities. Dietary composition and quality, food pyramid servings, physical activity, alcohol and smoking behaviours were examined.

Results: The prevalence of MHO varied considerably between definitions (2.2% to 11.9%), was higher among females and generally increased with age. Agreement between MHO classifications was poor. Among the obese, prevalence of MH was 6.8% to 36.6%. Among the non-obese, prevalence of metabolically unhealthy subjects was 21.8% to 87%. Calorie intake, dietary macronutrient composition, physical activity, alcohol and smoking behaviours were similar between the metabolically healthy and unhealthy regardless of BMI. Greater compliance with food pyramid recommendations and higher dietary quality were positively associated with metabolic health in obese (OR 1.45-1.53 unadjusted model) and non-obese subjects (OR 1.37-1.39 unadjusted model), respectively. Physical activity was associated with MHO defined by insulin resistance (OR 1.87, 95% CI 1.19-2.92, p = 0.006).

Conclusion: A standard MHO definition is required. Moderate and high levels of physical activity and compliance with food pyramid recommendations increase the likelihood of MHO. Stratification of obese individuals based on their metabolic health phenotype may be important in ascertaining the appropriate therapeutic or intervention strategy.

Citing Articles

The association between the lifestyle risk score and metabolically healthy and unhealthy obesity phenotype in Iranian women with overweight and obesity: a cross-sectional study.

Ebrahimi S, Shiraseb F, Ladaninezhad M, Izadi A, Navaei N, Mirzaei K Front Public Health. 2025; 13:1490937.

PMID: 40027500 PMC: 11868931. DOI: 10.3389/fpubh.2025.1490937.


Relationship between dietary intake and atherogenic index of plasma in cardiometabolic phenotypes: a cross-sectional study from the Azar cohort population.

Soheilifard S, Faramarzi E, Mahdavi R J Health Popul Nutr. 2025; 44(1):28.

PMID: 39920871 PMC: 11806714. DOI: 10.1186/s41043-025-00761-1.


Understanding the role of metabolic syndrome in prostate cancer risk: A UK Biobank prospective cohort study.

Lee S, Niksic M, Luque-Fernandez M Sci Rep. 2025; 15(1):2345.

PMID: 39824873 PMC: 11748637. DOI: 10.1038/s41598-025-85501-5.


Identification of metabolism related biomarkers in obesity based on adipose bioinformatics and machine learning.

Wang Y, Wang H, Yu X, Wu Q, Lv X, Zhou X J Transl Med. 2024; 22(1):986.

PMID: 39482740 PMC: 11526509. DOI: 10.1186/s12967-024-05615-8.


Trends and characteristics of the metabolically healthy obese phenotype in an Arab population.

Wani K, Kumar B, Al-Daghri N, Sabico S Front Public Health. 2024; 12:1371359.

PMID: 39145170 PMC: 11322095. DOI: 10.3389/fpubh.2024.1371359.


References
1.
Shin M, Hyun Y, Kim O, Kim J, Jang Y, Lee J . Weight loss effect on inflammation and LDL oxidation in metabolically healthy but obese (MHO) individuals: low inflammation and LDL oxidation in MHO women. Int J Obes (Lond). 2006; 30(10):1529-34. DOI: 10.1038/sj.ijo.0803304. View

2.
Van Gaal L, Mertens I, De Block C . Mechanisms linking obesity with cardiovascular disease. Nature. 2006; 444(7121):875-80. DOI: 10.1038/nature05487. View

3.
Wildman R, Muntner P, Reynolds K, McGinn A, Rajpathak S, Wylie-Rosett J . The obese without cardiometabolic risk factor clustering and the normal weight with cardiometabolic risk factor clustering: prevalence and correlates of 2 phenotypes among the US population (NHANES 1999-2004). Arch Intern Med. 2008; 168(15):1617-24. DOI: 10.1001/archinte.168.15.1617. View

4.
Cena H, Fonte M, Turconi G . Relationship between smoking and metabolic syndrome. Nutr Rev. 2011; 69(12):745-53. DOI: 10.1111/j.1753-4887.2011.00446.x. View

5.
Karelis A, Rabasa-Lhoret R . Inclusion of C-reactive protein in the identification of metabolically healthy but obese (MHO) individuals. Diabetes Metab. 2008; 34(2):183-4. DOI: 10.1016/j.diabet.2007.11.004. View